Introduction: Malignant mesothelioma (MM) is rare with poor prognosis and often diagnosed
at advanced stage. Systemic inflammatory indices (SII) may have prognostic value in cancer …

Aim: Malignant mesothelioma (MM) has a poor prognosis. Inflammation is associated with
MM prognosis and symptoms. Several inflammatory markers were investigated to estimate …

OBJECTIVE: The relationship between inflammatory markers and survival in many cancers
has been investigated previously. Inflammatory markers may also offer the possibility of …

Objective This study investigated the relationship between potential prognostic parameters
that may be associated with increased inflammation and survival in patients with malignant …

Objectives Inflammation plays a role in malignant pleural mesothelioma (MPM) prognosis
and symptoms. We investigated the roles of the new and old inflammatory indexes and …

Background In this study, we aimed to investigate the prognostic factors of malignant pleural
mesothelioma and the prognostic value of inflammation indices in malignant pleural …

Background: Malignant pleural mesothelioma (MPM) represents a fatal disease with high
aggressiveness, and limited biomarkers have yet been identified for MPM. The present study …

Background Malignant mesothelioma (MM) is an aggressive asbestos-related pleural tumor.
The incidence is increasing with intensive use of asbestos in developing countries. We need …

Background/Aims: To investigate differences in blood routine indexes and the expression of
cyclooxygenase-2 (COX-2) and nuclear factor-kappa B (NF-κB) in malignant peritoneal …

Aim: Malignant pleural mesothelioma (MPM) is an extremely mortal condition. Only a few
prognostic biomarkers have been described for MPM. Our study looked into the association …